Formuepleje A/S har dags dato offentliggjort ajourførte investoroplysninger i henhold til § 62 i Lov om forvaltere af alternative investeringsfonde mv. for Kapitalforeningen Formuepleje Pareto. Investoroplysningerne er tilrettet som følge af skift af depositar, udsteder og market maker til Danske Bank, med ikrafttrædelse pr. den 1. oktober 2019, som beskrevet i tidligere fondsbørsmeddelelser. Endelig er […]
Category Archives: Public Companies
Banco Comercial Português, S.A. informa sobre registo da fusão do Bank Millennium S.A. com o Euro Bank S.A.
About Us GlobeNewswire is one of the world’s largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public. © 2019 GlobeNewswire, Inc. All Rights Reserved. Related posts: Dassault Systèmes: declaration of the number of outstanding shares and […]
Kapitalforeningen Formuepleje Epikur – Opdaterede investoroplysninger
Kapitalforeningen Formuepleje Epikur – Opdaterede investoroplysninger Formuepleje A/S har dags dato offentliggjort ajourførte investoroplysninger i henhold til § 62 i Lov om forvaltere af alternative investeringsfonde mv. for Kapitalforeningen Formuepleje Epikur. Investoroplysningerne er tilrettet som følge af skift af depositar, udsteder og market maker til Danske Bank, med ikrafttrædelse pr. den 1. oktober 2019, som […]
Kapitalforeningen Formuepleje Fokus – Opdaterede investoroplysninger
Formuepleje A/S har dags dato offentliggjort ajourførte investoroplysninger i henhold til § 62 i Lov om forvaltere af alternative investeringsfonde mv. for Kapitalforeningen Formuepleje Fokus. Investoroplysningerne er tilrettet som følge af skift af udsteder og market maker til Danske Bank, med ikrafttrædelse pr. den 1. oktober 2019, som beskrevet i tidligere fondsbørsmeddelelser. Endelig er der […]
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity. Amsterdam, The Netherlands – 1st October 2019 Esperite N.V. (the Group) confirmed on 22nd February 2019 the intentions of the Group to sell its Cord Blood Stem Cells activities in an transaction composed by two main elements. The […]
TLC Announces Initiation of Phase III Pivotal Clinical Trial of TLC599 for the Treatment of Osteoarthritis Knee Pain
– Phase II results showed statistically significant pain relief through 24 weeks– Phase III to evaluate efficacy of single and repeated doses up to 52 weeks SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 01, 2019 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization […]
Net Asset Value(s)
WisdomTree Artificial Intelligence UCITS ETF – USD Acc 30/09/2019 IE00BDVPNG13 821000 USD 24,438,332.02 29.7665 WisdomTree AT1 CoCo Bond UCITS ETF – USD 30/09/2019 IE00BZ0XVF52 379396 USD 36,904,236.30 97.271 WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged 30/09/2019 IE00BFNNN236 38509 EUR 3,952,931.11 102.6495 WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged 30/09/2019 IE00BFNNN459 12040 […]
GROUPE IRD :DROITS DE VOTE ET D’ACTIONS AU 30 SEPTEMBRE 2019
GROUPE IRD Société Anonyme au capital de 44 274 913,25 €urosSiège social : 40, Rue Eugène Jacquet 59700 MARCQ-EN-BAROEUL456 504 877 R.C.S. LILLEEuronext Paris –Compartiment Ccode Isin FR 0000124232 COMMUNIQUE Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital socialArticle 233-8 du Code de Commercer et 223-16 du Règlement Général […]
Result of Riksbank certificate sale
October 01, 2019 04:15 ET | Source: Sveriges Riksbank CERTIFICATE MATURITY 191009 FIXED RATE -0.25 % OFFERED VOLUME 420.7 BLN TOTAL BID AMOUNT 429.9 BLN ACCEPTED VOLUME 420.7 BLN PERCENTAGE ALLOTTED 97.8600 % NUMBER OF BIDS 9 DEPOSIT RATE 0.50 % LENDING RATE -1.00% Stockholm, SWEDEN Media Files Formats available: Related […]
Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon
Philips Stellarex low dose drug coated balloon Philips International B.V. October 1, 2019 Primary safety analysis of Stellarex drug-coated balloon (DCB) three-year data, comprising the largest published, pooled set of randomized controlled trial (RCT) data for a single paclitaxel-based device, shows no difference in mortality between patients treated with the Philips Stellarex DCB and those […]